Education and Training
MD - University of Alabama School of Medicine, Birmingham, AL
Pediatrics - Children’s Hospital of Philadelphia, Philadelphia, PA
Child Neurology - Children’s Hospital of Philadelphia, Philadelphia, PA
PhD in Neurobiology - University of Alabama School of Medicine, Birmingham, AL
Titles and Academic Titles
Departments and Services
Cuddapah VA, Zhang SL, Sehgal A. (2019) Regulation of the blood-brain barrier by circadian rhythms and sleep. Trends in Neuroscience. Review. PMID: 31253251
Banka S, Sayer R, Breen C, Barton S, Pavaine J, Sheppard SE, Bedoukian E, Skraban C, Cuddapah VA, Clayton-Smith J. (2019) Genotype-phenotype specificity in Menke-Hennekam syndrome caused by missense variants in exon 30 or 31 of CREBBP. Am J Med Genet A. PMID: 30892814
Kahanovitch U*, Cuddapah VA*, Pacheco NL*, Holt LM, Mulkey DK, Percy AK, Olsen ML. (2018) MeCP2 Deficiency Leads to Loss of Glial Kir4.1. eNeuro. PMID: 29464197 * Denotes shared first- authorship
Nwaobi SE, Cuddapah VA, Patterson KC, Randolph AC, and Olsen ML. (2016) The role of glial- specific Kir4.1 in normal and pathological states of the CNS. Acta Neuropathologica. Review. PMID: 26961251
Cuddapah VA, Thompson M, Blount J, Li R, Saurabh G, and Goyal M. (2015) Hemispherectomy in hemimegalencephaly with tuberous sclerosis in a seven week old infant and a review of the literature. Pediatric Neurology. 53:452-5. PMID: 26231267
Cuddapah VA, Nwaobi SE, Percy AK, and Olsen ML. (2015) MECP2 in the regulation of neural activity: pathophysiological perspectives. Degenerative Neurological and Neuromuscular Disease. 5:103-116. Review.
Cuddapah VA, Pillai RB, Shekar KV, Lane JB, Motil KJ, Skinner SA, Tarquinio DC, Glaze DG, McGwin G, Kaufmann WE, Percy AK, Neul JL, Olsen ML. (2014) Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. Journal of Medical Genetics 51:152-8. PMID: 24399845 *Featured as the “Editor’s Choice” article.
Cuddapah VA, Robel S, Watkins S, and Sontheimer H. (2014) A neurocentric perspective on glioma invasion. Nature Reviews Neuroscience 15:455-65. Review. PMID: 24946761
Campbell SL, Robel S, Cuddapah VA, Robert S, Buckingham SC, Kahle KT, and Sontheimer H. (2014) GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor- associated epilepsy. Glia 63:23-36. PMID: 25066727
Cuddapah VA, Turner KL, Seifert S, Sontheimer H. (2013) Bradykinin-induced chemotaxis of human gliomas requires the activation of K Ca 3.1 and ClC-3. Journal of Neuroscience 33:1427-40. PMID: 23345219
McFerrin MB, Turner KL, Cuddapah VA, Sontheimer H. (2012) Differential Role of IK and BK Potassium Channels as Mediators of Intrinsic and Extrinsic Apoptotic Cell Death. Am J Physiol Cell Physiol 303:C1070-8. PMID: 22992678
Haas BR, Cuddapah VA, Watkins S, Rohn KJ, Dy TE, Sontheimer H. (2011) With-No-Lysine Kinase 3 (WNK3) Stimulates Glioma Invasion By Regulating Cell Volume. Am J Physiol Cell Physiol 301:C1150-60. PMID: 21813709
Cuddapah VA, Sontheimer H. (2011) Ion channels and transporters in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 301:C541-9. Review. PMID: 21543740
Cuddapah VA, Habela CW, Watkins S, Moore LS, Barclay TT, Sontheimer H. (2011) Kinase activation of ClC-3 accelerates cytoplasmic condensation during mitotic cell rounding. Am J Physiol Cell Physiol 302:C527-38. PMID:22049206
Cuddapah VA and Sontheimer H (2010) Molecular interaction and functional regulation of ClC-3 by Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma. Journal of Biological Chemistry 285:11188-96. PMID: 20139089
Corey DM and Cuddapah VA (2008) Delayed Auditory Feedback Effects during Reading and Conversation Tasks: Gender Differences in Fluent Adults. Journal of Fluency Disorders 33:291- 305. PMID: 19328981
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.